Immunoconjugates and long circulating systems: Origins, current state of the art and future directions

Abstract

Significant progress has been made recently in the area of immunoconjugated drugs and drug delivery systems (DDS). The immuno-modification of either the drug or DDS has proven to be a very promising approach that has significantly improved the targeted accumulation in pathological sites while decreasing its undesirable side effects in healthy tissues. The arrangement for both prolonged life in the circulation and specific target recognition represents another potent strategy in the development of immuno-targeted systems. The longevity of immuno-targeted DDS such as immunoliposomes and immunomicelles improves their targetability even in the presence of the additional passive accumulation in areas with a compromised vasculature. The added use of the immuno-targeted systems takes advantage of the specific microenvironment of pathological sites including lowered pH, increased temperature, and variation in the enzymatic activity. “Smart” stimulus-responsive systems combine different valuable functionalities including PEG-protection, targeting antibody, cell-penetration, and stimulus-sensitive functions. In this review we examined the evolution, current status and future directions in the area of therapeutical immunoconjugates and long-circulating immuno-targeted DDS.

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

“…To achieve true targeted delivery, liposomes must be modified on their surface with an agent that confers specificity. One possible approach is the conjugation of antibodies, antibody fragments, or single-chain antibodies to the liposomal surface [96,97].…”

Functionalization of liposomes: microscopical methods for preformulative screening

“…However, conventional liposomes are quickly cleared from the blood, mainly because of the adsorption of plasma opsonins onto the phospholipidic membranes, triggering their recognition and uptake by the mononuclear phagocytic system (MPS). Several studies describe the conjugation of hydrophilic polymers, usually derivatives of polyethylenglycol (PEG), to increase the circulating half-life avoiding liposome opsonization, recognition and clearance by MPS for enhancing the therapeutic efficacy of drugs (Koshkaryev et al, 2013;Marjan & Allen, 1996;Moghimi & Szebeni, 2003).…”

Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery

“…Both strategies can enhance selective accumulation and residence time of anticancer drugs in tumor. 98 …”